Grove Bank & Trust’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-170
Closed -$3.16K – 698
2023
Q3
$3.16K Buy
+170
New +$3.97K ﹤0.01% 611
2023
Q1
– Sell
-188
Closed -$4K – 749
2022
Q4
$4K Buy
+188
New +$5.07K ﹤0.01% 551

Other funds holding TDOC

Grove Bank & Trust's TDOC Position: Q4 2023 in Review

Grove Bank & Trust sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 170 shares — an estimated $3.16K sold.

Grove Bank & Trust first reported a position in TDOC in Q4 2022 and held it in 2 quarters. The position peaked at $4K in Q4 2022. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Grove Bank & Trust reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
  • Grove Bank & Trust sold 170 Teladoc Health shares in Q4 2023, an estimated $3.16K.
  • Grove Bank & Trust first reported a position in Teladoc Health in Q4 2022 and held it in 2 quarters.
  • Grove Bank & Trust's Teladoc Health position peaked at $4K in Q4 2022.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Grove Bank & Trust's 13F filing for Q4 2023, filed 30 Jan 2024.